Evidence map›Paper›PMID 33804894›Full record

ReviewPathogens (Basel, Switzerland)2021

Meysam Sarshar, Payam Behzadi, Daniela Scribano, Anna Teresa Palamara, Cecilia Ambrosi

Abstract readReview
In one paragraph

Review in Pathogens (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 119 papers.

0numbers the graph read from it
0cells of the map it votes in
119citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

119 citing papers in PubMed.

  1. Antimicrobial Resistance and Virulence ofAntibiotics (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. New Insights intoPathogens (Basel, Switzerland) · 2026
    Review
  5. Article
  6. Article
  7. Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2026
    Review
  8. Whole genome analysis of carbapenem resistantNew microbes and new infections · 2026
    Article
  9. Whole-Genome Sequencing of Multidrug-ResistantInternational journal of molecular sciences · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. The glutathione pathway is required for biofilm formation inCurrent research in microbial sciences · 2026
    Article
  15. Review
  16. Multidrug-ResistantAntibiotics (Basel, Switzerland) · 2025
    Review
  17. Article
  18. Article
  19. Global emergence ofMicrobial genomics · 2025
    Article
  20. Article

59 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Meysam SarsharResearch Laboratories, Bambino Gesù Children's Hospital, IRCCS, 00146 Rome, Italy.ORCID 0000-0002-5726-2090
Payam BehzadiDepartment of Microbiology, College of Basic Sciences, Shahr-e-Qods Branch, Islamic Azad University, Tehran 37541-374, Iran.ORCID 0000-0001-5441-3976
Daniela ScribanoDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0002-2901-265X
Anna Teresa PalamaraLaboratory affiliated to Institute Pasteur Italia- Cenci Bolognetti Foundation, Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0001-8330-4381
Cecilia AmbrosiIRCCS San Raffaele Pisana, 00166 Rome, Italy.ORCID 0000-0003-2163-1613

Funding

Dani Di Giò Foundation-Onlus 0000Ministero della Salute SG-2018-12365432
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acinetobacter baumanniiadherencecommunity-acquired infectionsinternalizationinvasionnosocomial infectionspersistencevirulence factors

Identifiers

PMID33804894
PMCPMC8063835

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.